Plenary Session I - Paradigm Shifts in Neuromodulation: Beyond Programming and Frequency Featured

8:00 AM - 10:00 AM Friday, January 18

This session will discuss advances in the field of neuromodulation and their role in improving patient outcomes. Topics covered will include the role of SCS trials and their predictive values on outcomes and the role of parathesias in pain control. In addition, advances in closed-loop stimulation will be discussed.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Identify the role of spinal cord stimulation trialing in patient selection.
  • Discuss the role of closed-loop neurostimulation.
  • Classify the types of pain effectively treated by neurostimulation.
  • Describe advances in the field of neurostimulation.

Trialing and SCS: Does Trialing Improve Outcomes

Sam S. Eldabe, MB ChB FRCA FFPMRCA

Neuromodulation and Neuropathic Pain: An Exclusive Relationship?

Eric E. Buchser, MD, DEAA

Paresthesia: A Noxious Side Effect or Therapeutic Benefit

Leonardo Kapural, MD, PhD

Closed Loop Neurostimulation: Is It Needed and Does It Improve Outcomes?

Nagy A. Mekhail, MD, PhD

Intra-Operative Neuromonitoring Recordings with Spinal Cord Stimulation: Elucidating Mechanisms of Action with Human Data

Steven M. Falowski, MD

Faculty subject to change.